Open16.620 | Close- |
Vol / Avg.2.010M / 2.290M | Mkt Cap4.329B |
Day Range16.425 - 17.005 | 52 Wk Range16.520 - 32.430 |
Organon Stock (NYSE: OGN) stock price, news, charts, stock research, profile.
Open16.620 | Close- |
Vol / Avg.2.010M / 2.290M | Mkt Cap4.329B |
Day Range16.425 - 17.005 | 52 Wk Range16.520 - 32.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.100 | (EXPECTED) 2023-11-02 | |||||
REV | 1.599B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.970 | 1.310 | 0.3400 | ||||
REV | 1.560B | 1.608B | 48.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-21 | Barclays | Balaji Prasad | Initiates Coverage On | Overweight | Announces | - | 28.00 |
2023-08-09 | Morgan Stanley | Terence Flynn | Maintains | Equal-WeightEqual-Weight | Raises | 25.00 | 27.00 |
2023-05-08 | Morgan Stanley | Terence Flynn | Maintains | Equal-Weight | Lowers | 26.00 | 25.00 |
2023-03-16 | Raymond James | Elliot Wilbur | Initiates Coverage On | Outperform | Announces | - | 33.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
OGN | Organon | 2.11% | 4.3B |
NVO | Novo Nordisk | -0.07% | 409.9B |
JNJ | Johnson & Johnson | -0.16% | 377.7B |
MRK | Merck & Co | 0.12% | 264.1B |
NVS | Novartis | 1.99% | 211.5B |
You can purchase shares of Organon (NYSE: OGN) through any online brokerage.
Other companies in Organon’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Organon (NYSE: OGN) was reported by Barclays on Thursday, September 21, 2023. The analyst firm set a price target for 28.00 expecting OGN to rise to within 12 months (a possible 65.29% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Organon (NYSE: OGN) is $16.94 last updated Today at September 28, 2023 at 5:53 PM UTC.
A quarterly cash dividend of $0.28 per share of Class A Common Stock. The quarterly cash dividend was payable on September 14, 2023 to stockholders of record on August 17, 2023.
Organon’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Organon.
Organon is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Organon Stock (NYSE: OGN) stock price, news, charts, stock research, profile.
Open16.620 | Close- |
Vol / Avg.2.010M / 2.290M | Mkt Cap4.329B |
Day Range16.425 - 17.005 | 52 Wk Range16.520 - 32.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.100 | (EXPECTED) 2023-11-02 | |||||
REV | 1.599B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.970 | 1.310 | 0.3400 | ||||
REV | 1.560B | 1.608B | 48.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-21 | Barclays | Balaji Prasad | Initiates Coverage On | Overweight | Announces | - | 28.00 |
2023-08-09 | Morgan Stanley | Terence Flynn | Maintains | Equal-WeightEqual-Weight | Raises | 25.00 | 27.00 |
2023-05-08 | Morgan Stanley | Terence Flynn | Maintains | Equal-Weight | Lowers | 26.00 | 25.00 |
2023-03-16 | Raymond James | Elliot Wilbur | Initiates Coverage On | Outperform | Announces | - | 33.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
OGN | Organon | 2.11% | 4.3B |
NVO | Novo Nordisk | -0.07% | 409.9B |
JNJ | Johnson & Johnson | -0.16% | 377.7B |
MRK | Merck & Co | 0.12% | 264.1B |
NVS | Novartis | 1.99% | 211.5B |
You can purchase shares of Organon (NYSE: OGN) through any online brokerage.
Other companies in Organon’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Organon (NYSE: OGN) was reported by Barclays on Thursday, September 21, 2023. The analyst firm set a price target for 28.00 expecting OGN to rise to within 12 months (a possible 65.29% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Organon (NYSE: OGN) is $16.94 last updated Today at September 28, 2023 at 5:53 PM UTC.
A quarterly cash dividend of $0.28 per share of Class A Common Stock. The quarterly cash dividend was payable on September 14, 2023 to stockholders of record on August 17, 2023.
Organon’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Organon.
Organon is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Organon Stock (NYSE: OGN) stock price, news, charts, stock research, profile.
Open16.620 | Close- |
Vol / Avg.2.010M / 2.290M | Mkt Cap4.329B |
Day Range16.425 - 17.005 | 52 Wk Range16.520 - 32.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.100 | (EXPECTED) 2023-11-02 | |||||
REV | 1.599B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.970 | 1.310 | 0.3400 | ||||
REV | 1.560B | 1.608B | 48.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-21 | Barclays | Balaji Prasad | Initiates Coverage On | Overweight | Announces | - | 28.00 |
2023-08-09 | Morgan Stanley | Terence Flynn | Maintains | Equal-WeightEqual-Weight | Raises | 25.00 | 27.00 |
2023-05-08 | Morgan Stanley | Terence Flynn | Maintains | Equal-Weight | Lowers | 26.00 | 25.00 |
2023-03-16 | Raymond James | Elliot Wilbur | Initiates Coverage On | Outperform | Announces | - | 33.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
OGN | Organon | 2.11% | 4.3B |
NVO | Novo Nordisk | -0.07% | 409.9B |
JNJ | Johnson & Johnson | -0.16% | 377.7B |
MRK | Merck & Co | 0.12% | 264.1B |
NVS | Novartis | 1.99% | 211.5B |
You can purchase shares of Organon (NYSE: OGN) through any online brokerage.
Other companies in Organon’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Organon (NYSE: OGN) was reported by Barclays on Thursday, September 21, 2023. The analyst firm set a price target for 28.00 expecting OGN to rise to within 12 months (a possible 65.29% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Organon (NYSE: OGN) is $16.94 last updated Today at September 28, 2023 at 5:53 PM UTC.
A quarterly cash dividend of $0.28 per share of Class A Common Stock. The quarterly cash dividend was payable on September 14, 2023 to stockholders of record on August 17, 2023.
Organon’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Organon.
Organon is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Organon Stock (NYSE: OGN) stock price, news, charts, stock research, profile.
Open16.620 | Close- |
Vol / Avg.2.010M / 2.290M | Mkt Cap4.329B |
Day Range16.425 - 17.005 | 52 Wk Range16.520 - 32.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.100 | (EXPECTED) 2023-11-02 | |||||
REV | 1.599B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.970 | 1.310 | 0.3400 | ||||
REV | 1.560B | 1.608B | 48.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-21 | Barclays | Balaji Prasad | Initiates Coverage On | Overweight | Announces | - | 28.00 |
2023-08-09 | Morgan Stanley | Terence Flynn | Maintains | Equal-WeightEqual-Weight | Raises | 25.00 | 27.00 |
2023-05-08 | Morgan Stanley | Terence Flynn | Maintains | Equal-Weight | Lowers | 26.00 | 25.00 |
2023-03-16 | Raymond James | Elliot Wilbur | Initiates Coverage On | Outperform | Announces | - | 33.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
OGN | Organon | 2.11% | 4.3B |
NVO | Novo Nordisk | -0.07% | 409.9B |
JNJ | Johnson & Johnson | -0.16% | 377.7B |
MRK | Merck & Co | 0.12% | 264.1B |
NVS | Novartis | 1.99% | 211.5B |
You can purchase shares of Organon (NYSE: OGN) through any online brokerage.
Other companies in Organon’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Organon (NYSE: OGN) was reported by Barclays on Thursday, September 21, 2023. The analyst firm set a price target for 28.00 expecting OGN to rise to within 12 months (a possible 65.29% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Organon (NYSE: OGN) is $16.94 last updated Today at September 28, 2023 at 5:53 PM UTC.
A quarterly cash dividend of $0.28 per share of Class A Common Stock. The quarterly cash dividend was payable on September 14, 2023 to stockholders of record on August 17, 2023.
Organon’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Organon.
Organon is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Organon Stock (NYSE: OGN) stock price, news, charts, stock research, profile.
Open16.620 | Close- |
Vol / Avg.2.010M / 2.290M | Mkt Cap4.329B |
Day Range16.425 - 17.005 | 52 Wk Range16.520 - 32.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.100 | (EXPECTED) 2023-11-02 | |||||
REV | 1.599B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.970 | 1.310 | 0.3400 | ||||
REV | 1.560B | 1.608B | 48.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-21 | Barclays | Balaji Prasad | Initiates Coverage On | Overweight | Announces | - | 28.00 |
2023-08-09 | Morgan Stanley | Terence Flynn | Maintains | Equal-WeightEqual-Weight | Raises | 25.00 | 27.00 |
2023-05-08 | Morgan Stanley | Terence Flynn | Maintains | Equal-Weight | Lowers | 26.00 | 25.00 |
2023-03-16 | Raymond James | Elliot Wilbur | Initiates Coverage On | Outperform | Announces | - | 33.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
OGN | Organon | 2.11% | 4.3B |
NVO | Novo Nordisk | -0.07% | 409.9B |
JNJ | Johnson & Johnson | -0.16% | 377.7B |
MRK | Merck & Co | 0.12% | 264.1B |
NVS | Novartis | 1.99% | 211.5B |
You can purchase shares of Organon (NYSE: OGN) through any online brokerage.
Other companies in Organon’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Organon (NYSE: OGN) was reported by Barclays on Thursday, September 21, 2023. The analyst firm set a price target for 28.00 expecting OGN to rise to within 12 months (a possible 65.29% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Organon (NYSE: OGN) is $16.94 last updated Today at September 28, 2023 at 5:53 PM UTC.
A quarterly cash dividend of $0.28 per share of Class A Common Stock. The quarterly cash dividend was payable on September 14, 2023 to stockholders of record on August 17, 2023.
Organon’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Organon.
Organon is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Organon Stock (NYSE: OGN) stock price, news, charts, stock research, profile.
Open16.620 | Close- |
Vol / Avg.2.010M / 2.290M | Mkt Cap4.329B |
Day Range16.425 - 17.005 | 52 Wk Range16.520 - 32.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.100 | (EXPECTED) 2023-11-02 | |||||
REV | 1.599B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.970 | 1.310 | 0.3400 | ||||
REV | 1.560B | 1.608B | 48.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-21 | Barclays | Balaji Prasad | Initiates Coverage On | Overweight | Announces | - | 28.00 |
2023-08-09 | Morgan Stanley | Terence Flynn | Maintains | Equal-WeightEqual-Weight | Raises | 25.00 | 27.00 |
2023-05-08 | Morgan Stanley | Terence Flynn | Maintains | Equal-Weight | Lowers | 26.00 | 25.00 |
2023-03-16 | Raymond James | Elliot Wilbur | Initiates Coverage On | Outperform | Announces | - | 33.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
OGN | Organon | 2.11% | 4.3B |
NVO | Novo Nordisk | -0.07% | 409.9B |
JNJ | Johnson & Johnson | -0.16% | 377.7B |
MRK | Merck & Co | 0.12% | 264.1B |
NVS | Novartis | 1.99% | 211.5B |
You can purchase shares of Organon (NYSE: OGN) through any online brokerage.
Other companies in Organon’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Organon (NYSE: OGN) was reported by Barclays on Thursday, September 21, 2023. The analyst firm set a price target for 28.00 expecting OGN to rise to within 12 months (a possible 65.29% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Organon (NYSE: OGN) is $16.94 last updated Today at September 28, 2023 at 5:53 PM UTC.
A quarterly cash dividend of $0.28 per share of Class A Common Stock. The quarterly cash dividend was payable on September 14, 2023 to stockholders of record on August 17, 2023.
Organon’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Organon.
Organon is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Organon Stock (NYSE: OGN) stock price, news, charts, stock research, profile.
Open16.620 | Close- |
Vol / Avg.2.010M / 2.290M | Mkt Cap4.329B |
Day Range16.425 - 17.005 | 52 Wk Range16.520 - 32.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.100 | (EXPECTED) 2023-11-02 | |||||
REV | 1.599B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.970 | 1.310 | 0.3400 | ||||
REV | 1.560B | 1.608B | 48.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-21 | Barclays | Balaji Prasad | Initiates Coverage On | Overweight | Announces | - | 28.00 |
2023-08-09 | Morgan Stanley | Terence Flynn | Maintains | Equal-WeightEqual-Weight | Raises | 25.00 | 27.00 |
2023-05-08 | Morgan Stanley | Terence Flynn | Maintains | Equal-Weight | Lowers | 26.00 | 25.00 |
2023-03-16 | Raymond James | Elliot Wilbur | Initiates Coverage On | Outperform | Announces | - | 33.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
OGN | Organon | 2.11% | 4.3B |
NVO | Novo Nordisk | -0.07% | 409.9B |
JNJ | Johnson & Johnson | -0.16% | 377.7B |
MRK | Merck & Co | 0.12% | 264.1B |
NVS | Novartis | 1.99% | 211.5B |
You can purchase shares of Organon (NYSE: OGN) through any online brokerage.
Other companies in Organon’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Organon (NYSE: OGN) was reported by Barclays on Thursday, September 21, 2023. The analyst firm set a price target for 28.00 expecting OGN to rise to within 12 months (a possible 65.29% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Organon (NYSE: OGN) is $16.94 last updated Today at September 28, 2023 at 5:53 PM UTC.
A quarterly cash dividend of $0.28 per share of Class A Common Stock. The quarterly cash dividend was payable on September 14, 2023 to stockholders of record on August 17, 2023.
Organon’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Organon.
Organon is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Organon Stock (NYSE: OGN) stock price, news, charts, stock research, profile.
Open16.620 | Close- |
Vol / Avg.2.010M / 2.290M | Mkt Cap4.329B |
Day Range16.425 - 17.005 | 52 Wk Range16.520 - 32.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.100 | (EXPECTED) 2023-11-02 | |||||
REV | 1.599B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.970 | 1.310 | 0.3400 | ||||
REV | 1.560B | 1.608B | 48.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-21 | Barclays | Balaji Prasad | Initiates Coverage On | Overweight | Announces | - | 28.00 |
2023-08-09 | Morgan Stanley | Terence Flynn | Maintains | Equal-WeightEqual-Weight | Raises | 25.00 | 27.00 |
2023-05-08 | Morgan Stanley | Terence Flynn | Maintains | Equal-Weight | Lowers | 26.00 | 25.00 |
2023-03-16 | Raymond James | Elliot Wilbur | Initiates Coverage On | Outperform | Announces | - | 33.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
OGN | Organon | 2.11% | 4.3B |
NVO | Novo Nordisk | -0.07% | 409.9B |
JNJ | Johnson & Johnson | -0.16% | 377.7B |
MRK | Merck & Co | 0.12% | 264.1B |
NVS | Novartis | 1.99% | 211.5B |
You can purchase shares of Organon (NYSE: OGN) through any online brokerage.
Other companies in Organon’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Organon (NYSE: OGN) was reported by Barclays on Thursday, September 21, 2023. The analyst firm set a price target for 28.00 expecting OGN to rise to within 12 months (a possible 65.29% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Organon (NYSE: OGN) is $16.94 last updated Today at September 28, 2023 at 5:53 PM UTC.
A quarterly cash dividend of $0.28 per share of Class A Common Stock. The quarterly cash dividend was payable on September 14, 2023 to stockholders of record on August 17, 2023.
Organon’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Organon.
Organon is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Organon Stock (NYSE: OGN) stock price, news, charts, stock research, profile.
Open16.620 | Close- |
Vol / Avg.2.010M / 2.290M | Mkt Cap4.329B |
Day Range16.425 - 17.005 | 52 Wk Range16.520 - 32.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.100 | (EXPECTED) 2023-11-02 | |||||
REV | 1.599B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.970 | 1.310 | 0.3400 | ||||
REV | 1.560B | 1.608B | 48.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-21 | Barclays | Balaji Prasad | Initiates Coverage On | Overweight | Announces | - | 28.00 |
2023-08-09 | Morgan Stanley | Terence Flynn | Maintains | Equal-WeightEqual-Weight | Raises | 25.00 | 27.00 |
2023-05-08 | Morgan Stanley | Terence Flynn | Maintains | Equal-Weight | Lowers | 26.00 | 25.00 |
2023-03-16 | Raymond James | Elliot Wilbur | Initiates Coverage On | Outperform | Announces | - | 33.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
OGN | Organon | 2.11% | 4.3B |
NVO | Novo Nordisk | -0.07% | 409.9B |
JNJ | Johnson & Johnson | -0.16% | 377.7B |
MRK | Merck & Co | 0.12% | 264.1B |
NVS | Novartis | 1.99% | 211.5B |
You can purchase shares of Organon (NYSE: OGN) through any online brokerage.
Other companies in Organon’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Organon (NYSE: OGN) was reported by Barclays on Thursday, September 21, 2023. The analyst firm set a price target for 28.00 expecting OGN to rise to within 12 months (a possible 65.29% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Organon (NYSE: OGN) is $16.94 last updated Today at September 28, 2023 at 5:53 PM UTC.
A quarterly cash dividend of $0.28 per share of Class A Common Stock. The quarterly cash dividend was payable on September 14, 2023 to stockholders of record on August 17, 2023.
Organon’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Organon.
Organon is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.